Companies specializing in gene therapy must ensure that the right medicine makes it to the right person, at the right time, every single time. Gene therapy is at the forefront of medicine, making it a sensitive process that requires a centralized and complete record of identity so that brands can track their products every step of the way.
Gene products are personalized cures designed for a specific individual, based on their specific genetic making. Such medications are always critical and must be administered by adhering to strict and specific protocols. Often, these therapies modify the DNA of a patient’s specific blood cells (the T cells for example) so that the modified cells can be re-injected into the patient to attack and destroy the cancer. The supply chain of these sensitive products must guarantee the integrity and identity of the patient from the moment cells are removed to be modified until re-injection.
The Adept Connect Chain of Identity Solution is an advanced application of the Track and Trace technology within gene therapy that ensures complete visibility of an individual unit throughout the supply chain and incorporates infallibility of the association between product and individual.
The experts at Adept are revolutionizing the way Track and Trace technology can be applied to gene therapy and all aspects of a company’s supply chain. With experience in helping over 100 clients across pharmaceuticals, medical devices, packaged goods, food & beverage, Adept is uniquely positioned to aggregated best practices seamlessly.